Article
XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.
PloS one - 1 Jan 2013
Qiu Mantang, Xu Lei, Yang Xin, Ding Xiangxiang, Hu Jingwen, Jiang Feng, Xu Lin, Yin Rong
Abstract excerpt
BACKGROUND: A lot of studies have investigated the correlation between x-ray repair cross-complementing group 3 (XRCC3) Thr241Met polymorphism and clinical outcomes in non-small cell cancer (NSCLC), while the conclusion is still conflicting. MATERIALS AND METHODS: We conducted this meta-analysis to evaluate the predictive value of XRCC3 Thr241Met polymorphism on response and overall survival of patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
